A B S T R A C T A X, IgAl myeloma protein that formed two chain half-molecules was obtained from a patient who had typical multiple myeloma. His serum contained 1.3 g/100 ml of an IgA paraprotein of y-1 electrophoretic mobility, his urine predominantly X Bence Jones protein, and only small amounts of IgA paraprotein. Analytical ultracentrifugation of the isolated serum IgA protein showed 7.OS and 4.5S protein peaks but no IgA polymers. When the 7.0S and 4 .5S protein peaks were tested with an antiserum specific for a chain, both fractions were antigenically deficient compared to control IgA myeloma proteins but showed a line of identity to their F(ab')2 fragments. The serum and 7.0S protein fraction showed double precipitin lines in IgA radial immunodiffusion plates and in immunoelectrophoretic analysis, one line being formed by the myeloma protein and the other by residual normal IgA. The myeloma protein did not form a precipitin line with antisera specific for the IgA Fc fragment. Sodium dodecylsulfate-urea-polyacrylamide gel electrophoresis demonstrated that both the 7.OS and 4.5S fractions ofthe myeloma protein consisted ofcovalently linked heavy and light chains, the 4.5S fraction being apparently the half-molecule of the 7.OS protein. The heavy chain had a mol wt of 46,500 daltons compared to 55,000 daltons for normal a chains. Reduction and alkylation in aqueous solutions resulted in dissociation of the 7.OS myeloma protein fractions into smaller units, probably half-molecules, suggesting that the noncovalent interactions between the a chains were substantially weakened or absent, presumably as a result of a deletion in the Fc Received for publication 7 May 1976 and in revised form 13 July 1976.
The Journal of Clinical Investigation Volume 58 Nov labeled 7.OS and 4.5S proteins in rhesus monkeys were similar to those of control IgA myeloma proteins; the excretion of protein-bound radioactivity of the IgA half-molecules into the urine was no greater than that of the 7.OS or of control IgA myeloma proteins. It is suggested that the myeloma IgA half-molecule is probably derived from an IgAl mutant that is carried in the human genome and that it is unlikely a representative of a rare IgA subclass or an IgA 1 allotypic variant.
INTRODUCTION
IgG half-molecules consisting of one heavy and one light chain were first described as a normal component in sera of colostrum deprived piglets (1, 2) . Subsequently, IgA half-molecules were detected in the urine of mice bearing mineral oil-induced plasmacytomas (3) . Recently, several patients with myeloma who excreted IgG half-molecules into their urine have been described (4) (5) (6) . Structural analysis of the murine and human half-molecules indicated that these immunoglobulins (Ig)l had a deletion in the heavy chain (7) (8) (9) . The deletion caused a weakness or absence of the noncovalent interactions normally present between Ig heavy chains and apparently resulted in an incomplete assembly of typical four chain Ig. The "hinge" region containing the half-cystine residues forming the inter-heavy chain disulfide bonds, appeared to be normal in the single case of IgG halfmolecules that was studied for this parameter (8) . This explained why this patient's serum contained two chain half-molecules and small amounts of four chain Ig molecules that were produced by the same clone of tumor cells.
The human IgG half-molecules were antigenically deficient in the Fc fragment (8) immunodiffusion plates (6) . The patient's serum showed a double precipitin ring, one formed by the antigenically deficient myeloma protein and the other by the residual normal IgG. We describe in this report an IgA myeloma protein that formed halfmolecules which simulated IgG half-molecules in both its antigenic and structural features.
Clinical history. Patient Ka, a 57 yr-old man was admitted to a hospital on 7/1/74 because of a traumatic fracture of the right foot. He had back pain for 4 mo before admission which had intensified 10 days before admission and was not relieved by Butazolidin and "pain pills". 3 days before admission, the patient became apathetic and confused. On admission the patient was dehydrated, confused, and disoriented and had a swollen and discolored right foot. The pertinent laboratory data were: hemoglobin, 9.2 g/100 ml; calcium, 17.4; phosphorus, 4.5; blood, urea, nitrogen, 107; and uric acid, 15.5 mg/100 ml. A skeletal survey demonstrated radiolucencies in the skull, iliac wings, inferior pubic rami, right greater trochanter, and anterior body of the fifth cervical vertebra. A compression fracture of the first lumbar vertebra and traumatic fractures of the second and third metatarsal bones were present. A bone marrow aspiration failed to yield cells, but a bone marrow biopsy showed an anaplastic multiple myeloma. Prednisone (200 mg/day) and saline therapy reversed the hypercalcemic state and the patient became alert and his renal status improved. The serum electrophoresis values were: total protein, 6.5; albumin, 3.1; a1, 0.2; a2, 0.7; 3, 2.2; and y, 0.2 g/100 ml. Quantitative immunoglobulins were: IgG, 280; IgA, 2,900; and IgM, 44 mg/100 ml. Alkeran therapy was instituted on 7/13. Serum and urine specimens were submitted to our laboratory on 7/16; the serum electrophoresis values were: total protein, 7.1; albumin, 2.7; a1, 0.4; a2, 1.1; , 1.0; -y, 1.3; and Y2, 0.6 g/100 ml. The urine contained 88 mg protein/100 ml and METHODS A single specimen of serum and urine obtained 23 days before the patient expired was available for study. The urine was dialyzed against 0.01 M phosphate buffer, pH 8.0, and lyophilized and dissolved in phosphate buffered 0.15M NaCl, pH 7.0 (saline). The myeloma protein was isolated from the serum by Pevikon block electrophoresis followed by Sephadex G-200 gel filtration. (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) Protein concentrations of the isolated IgA fractions were determined by optical density employing an extinction coefficient of E28o nm, icm1.% = 15.
IgA myeloma proteins isolated from serum of other patients by Pevikon block electrophoresis and Sephadex G-200 gel filtration served as controls. They were digested with pepsin (10) for 6 h at 370C to prepare F(ab')2 fragments. A longer digestion period of 18 h resulted in almost complete digestion of the IgA proteins. The F(ab')2 fragments were isolated from undigested IgA by Sephadex G-200 gel filtration. The undigested IgA separated poorly from the F(ab')2 fragments and the F(ab')2 preparations contained traces of undigested IgA. Reduction and alkylaFIGuRE 2 Immunoelectrophoresis of normal serum (2, 5) , and Ka serum (1, 4) , and 50-fold concentrated urine (3, 6) employing specific antisera to a chain (A) and IgA Fc fragment (B Fig. 1 . The serum showed a relatively broad monoclonal bond of Yi electrophoretic mobility and the urine showed a sharply delineated slightly more anodal monoclonal band. The concentration of the myeloma protein in the serum was 1.3 g/100 ml and the monoclonal protein in the urine was 62 mg/100 ml. Immunoelectrophoresis demonstrated a X, IgA protein in the serum, and large amounts of X chain FIGURE 4 Radial immunodiffusion employing an anti-a chain antiserum. Wells 1 and 2 contained a control IgA myeloma protein at 6 and 3 mg/ml, respectively. Wells 3 and 4 contained Ka serum diluted 1:5 and 1:10. Well 5 contained 50-fold concentrated urine.
in the urine. The antigenic reaction with the anti-a anti-serum was abnormal. It showed a double precipitin arc with the serum of the patient (Fig. 2) . The concentrated urine also reacted with the antia antiserum by showing a single arc of a more anodic mobility than the arc seen with the anti-X antiserum (Fig. 3) . When an antiserum rendered specific for the IgA Fc fragment was used, only a single precipitin line was observed with the Ka patient serum and no reaction with the urine. Double precipitin lines were also observed in radial immunodiffusion plates with both serum and urine of the patient (Fig. 4 (Fig. 1) . When the isolated 7.OS and 4.5S myeloma protein fractions were analyzed by double gel diffusion employing antisera to a chain, both the 7.OS and 4.5S fractions were antigenically deficient when compared to control IgA myeloma proteins as indicated by a spur formation (Fig. 6) Typing for genetic markers of the half-molecule, kindly performed by Dr. Erna van Loghem, showed absence of a2 and presence of a and al determinants and clearly n A2m(2), the isoallotype occurring on IgAl and A2m (1) proteins. The Gm-Km haplotype is prevalent in Caucasians: yl,f; y2,n; y3,b0,bl,b3,b5; a2,1 and K,3.
Structural analyses. The Ka Pevikon, 7.OS and 4.5S fractions were analyzed in both native and reduced states by polyacrylamide gel electrophoresis in 1% sodium dodecyl sulfate (Fig. 7) . The native Pevikon fraction showed two major and one minor band. The two major bands corresponded to the 7.OS and 4.5S fractions and the minor band had a mobility r'efDduc ' uippmpi 41W FIGURE 7 Polyacrylamide gel electrophoresis in 1% sodium dodecylsulfate analysis of unreduced 7.OS (1), Pevikon (2), and 4.5S (3) Ka IgA protein fractions and reduced control IgA myeloma protein (4), 4.5S (6), and 7.OS (7) , and mixture of control IgA and 4.5S fraction (5 Fig. 8 , the radioactivity representing the native Ka 7.0S fraction eluted slightly after the monomeric IgA protein. By contrast, most of the reduced protein Ka eluted after the control IgA protein which remained a 7.0S protein as all structurally intact Ig do after reduction in aqueous solutions.
Turnover studies. The Ka 7.OS and 4.5S fractions were labeled with 131I and injected together with 125I-labeled control IgA myeloma proteins into rhesus monkeys. As can be seen in Fig. 9 , all preparations were eliminated at a comparable rate from the circulation and were excreted in part into the urine. The serum half-lives varied from 1.5 to 2.7 days, the fractional turnover rates from 87 to 127% of the intravascular pool and 3.5 to 8.9% of the intravascular pool was recovered in the urine as trichloroacetic acid precipitable radioactivity. The amount of trichloroacetic acid precipitable radioactivity excreted into the DISCUSSION The Ka IgA myeloma protein existed in the patient's serum in two molecular species, one being ofthe classical 7.OS covalent four chain structure and the other a 4.5S two chain half-molecule. Both species were antigenically deficient in the Fc fragment and their a chains had a deletion of about 8,500 daltons. The deletion probably caused the absence or at least great diminution of the noncovalent interactions between the a chains and also was most likely responsible for an incomplete assembly of all myeloma proteins to 7.OS four chain Ig molecules. These findings strikingly parallel the characteristics of a human IgG myeloma protein forming half-molecules that was recently studied in our laboratory (8) . Like the IgA myeloma protein, the IgG myeloma protein had a deletion in the Fc fragment, which in the latter was localized as an internal deletion of the third constant domain of the y chain. The 7.OS IgG myeloma molecules also dissociated into half-molecules after mild reduction and alkylation in aqueous solutions, indicative of a lack of noncovalent interactions between the y chains. It is conceivable that deletions of analogous structures in both a and y chains are responsible for half-molecule formation. 
IgA Half-Molecules
IgA half-molecules have previously only been found in mice bearing mineral oil-induced plasmacytomas (3, 9, 14) . The a chains of one of these aberrant proteins were shown to have a deletion of about 12,000 daltons and involved the entire third constant domain (9) . This deletion may be larger than that of the Ka protein whose a chain lacked approximately 8,500 daltons; however, the possibility exists that the presence of additional carbohydrate side chains could have obscured a larger deletion in the Ka a chain. Four (19, 20) and that the murine tumors forming IgA half-molecules arose as mutants from tumor cell lines producing intact IgA (3, 14) . An originally intact IgA-producing tumor could have been present in the patient and later was replaced by a mutant. This seems unlikely to have happened in the short time of clinical disease, as one would have expected to find complete IgA molecules formed by the initial tumor in the serum. It appears probable that the myeloma cells arose from a natural clone of cells forming IgA half-molecules. The presence of IgA half-molecules in normal human serum would support this premise. To our knowledge, IgA half-molecules have not been reported in man, but a careful search has not been made. In rabbits, nonprecipitating antibodies of a 4.3S rate similar to the half-molecule have been described (21) and the serum of colostrum deprived piglets contains IgG half-molecules (1, 2). It is conceivable that a careful search will subsequently disclose IgA half-molecules in normal human serum and this finding will support the notion that the Ka IgA half-molecule is derived from an IgAl mutant that is carried in the human genome. also had a deletion and its mol wt was 45,000 daltons. It was postulated that the deletion affected the third constant domain ofthe a chain because it lacked methionine residues.
